Nepuvibart [2640224-48-0]

TargetMol Chemicals

Nepuvibart

9

2640224-48-0

Antibody

Research Use Only

Nepuvibart

Nepuvibart (ZRC3308-B10), an IgG1 type anti-SARS-CoV-2 monoclonal antibody, exhibits strong binding affinity to a distinct non-competing epitope on the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein. When combined in a 1:1 ratio with ZRC3308-A7, Nepuvibart is effective in preventing COVID-19 and in treating the early stages of the disease before it progresses to severe illness [1].

3 years

-20°C

12352203